| Patient | Marcus Aurelius |
|---|---|
| Date of birth | 1973-04-25 |
| Identifiers | MRN HR-AC004-SYN; SSN (made up) 000-04-1213 |
| Document date | 2026-08-25 |
| Author | Octavia Ashworth-Nnamdi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Fifteen-week review: on-demand omeprazole, sleep, the remedy, and mood. [S]
Mr. Aurelius returns six weeks after finishing the eight-week omeprazole course. He has taken omeprazole on demand about once a week, after a late dinner, and has had no chest or epigastric pain otherwise. His appetite is good and he has regained most of the weight he had lost. He has finished six CBT-I sessions and sleeps about six and a half hours, falling asleep within twenty minutes. About four weeks ago he chose to take the herbal paste on only two nights a week, a smaller amount, and noticed only a night or two of lighter sleep. He has no craving and takes no more on the nights he uses it. The COVID-19 illness in July left no after-effects. He says he feels clearer in the mornings and is working shorter evenings. [S]
| Element | Detail |
|---|---|
| Reflux | On-demand omeprazole about once a week; no pain otherwise |
| Sleep | Six CBT-I sessions completed; Insomnia Severity Index 7 |
| Remedy | About two nights a week, smaller amount, for four weeks, by his choice; no craving |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight regained; energy good |
| Gastrointestinal | Positive | Occasional heartburn after a late dinner, eased by omeprazole; no difficulty swallowing, vomiting or black stools |
| Cardiovascular | Negative | No chest pain |
| Psychiatric | Negative | Mood good; sleeping better; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long day | About 0.5 g at bedtime most nights; occasionally a second amount in the morning | Oral route | 2020-05-01 to 2026-06-06 | completed | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopy | One or two tablets as needed, at least four hours apart; no more than six a day | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation | 17 g once daily as needed | Oral route | 2026-05-12 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 | One spray for suspected overdose; repeat every 2 to 3 minutes if needed | Nasal route | 2026-05-12 | active | S |
| Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis | One capsule each morning before breakfast for eight weeks | Oral route | 2026-05-19 to 2026-07-14 | completed | S |
| Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course) | One capsule on a day with heartburn; no more than one a day | Oral route | 2026-07-14 | active | S |
| Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself | About 0.5 g at bedtime every other night | Oral route | 2026-06-06 to 2026-07-28 | completed | S |
| Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he chose | About 0.3 g at bedtime on about two nights a week | Oral route | 2026-07-28 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a day | One or two tablets every six hours as needed; no more than six a day | Oral route | 2026-07-07 to 2026-07-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-25 | Body height | 172 | cm | S |
| 2026-08-25 | Body weight | 65 | kg | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 22 | kg/m2 | S |
| 2026-08-25 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-08-25 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-25 | Heart rate | 70 | /min | S |
| 2026-08-25 | Respiratory rate | 14 | /min | S |
| 2026-08-25 | Body temperature | 36.6 | Cel | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-25 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-08-25 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S |
Vital signs recorded on 2026-08-25; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 65.0 kg, BMI 22.0; pulse 70, blood pressure 118/76 |
| Abdomen | Soft and non-tender |
| Neurological | Calm; no signs of withdrawal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excluded | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D). |
| Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaints | active | confirmed | K21.00 | S — Synthetic modern diagnosis; the cause of his real complaints is unknown and no historical diagnosis is made. |
| Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioid | active | confirmed | F11.90 | S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R). |
| Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate) | active | confirmed | G47.00 | S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible). |
| Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little rest | active | confirmed | Z56.6 | S — Synthetic work strain anchored to his documented years on campaign (D). |
| Constipation from the opioid in his remedy: hard stools every two or three days | active | confirmed | K59.03 | S — Synthetic finding at intake. |
| COVID-19, mild (rapid antigen test positive), without breathlessness or low oxygen; antiviral treatment offered and declined; resolved | resolved | confirmed | U07.1 | S — Synthetic intercurrent illness; not a claim about the Antonine Plague or about any illness in his lifetime. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Reflux symptoms: heartburn, chest pain after meals, regurgitation, night waking | Every visit | Completed today | Occasional heartburn after late dinners only |
| Examination | Alarm features: difficulty or pain swallowing, bleeding, vomiting, weight loss, anemia | Every visit | Completed today | None; weight 65.0 kg |
| Medication safety | Proton pump inhibitor: dose, timing before breakfast, and adherence | Eight weeks for erosive esophagitis, then the lowest effective dose or on demand | Completed today | Eight-week course finished; on demand about once a week |
| Imaging | Repeat endoscopy | Only for Los Angeles grade C or D esophagitis or new alarm features | Not indicated | Grade B esophagitis with no alarm features |
| Self-management | Meal timing, head-of-bed elevation, alcohol at night | Every visit | Completed today | Early main meal; head of bed raised |
| Medication safety | Opium-containing remedy: amount, pattern, benefits and harms, his own goals | Every visit | Completed today | About two nights a week, a smaller amount, by his choice |
| Medication safety | Reassessment after a change in opioid use | Within one to four weeks of a change | Completed today | Reviewed about four weeks after his last change; reviewed at the sick and preventive visits after the first |
| Medication safety | Naloxone at home and no alcohol or sedatives with the remedy | Every visit | Completed today | In date at the bedside |
| Medication safety | DSM-5-TR opioid use disorder criteria | At intake and when the pattern changes | Completed today | No criterion present |
| Laboratory | Urine drug test with consent | At intake, then at least yearly while he uses an opioid | Up to date | Intake test showed morphine and codeine only; next in a year, with consent |
| Survey | Suicide risk and safety review | Every visit | Completed today | No thoughts of self-harm |
| Survey | PHQ-9 and GAD-7 | At intake, at follow-up and at the end of the episode | Completed today | PHQ-9 3; GAD-7 3 |
| Survey | Insomnia Severity Index | At intake and at each review | Completed today | 7, below the threshold for clinical insomnia |
| Self-management | Cognitive behavioral therapy for insomnia (six sessions) with sleep diary | Six sessions | Completed today | All six sessions completed |
| Self-management | Constipation on the opioid | Every visit | Completed today | Laxative rarely needed |
| Laboratory | Cardiovascular risk and statin decision | Every four to six years by the PREVENT equations | Up to date | Low risk with a calcium score of 0; no statin |
| Medication safety | Hepatitis B vaccine, dose 2 | At least four weeks after dose 1 | Completed today | HepB-CpG dose 2 given today |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2 [S]
Guideline basis: ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (2022); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, hyperlipidemia and ischemic heart disease monographs (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Review in six months, or sooner if heartburn returns most days, sleep slips, or he wants help with the remedy. Second zoster dose in two to six months after the first; influenza vaccine in the autumn; colonoscopy as ordered. [S]